Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate

Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate

There currently is no therapeutic drug treatment for traumatic brain injury (TBI) despite decades of experimental clinical trials. This may be because the mechanistic pathways for improving TBI outcomes have yet to be identified and exploited. As such, there remains a need to seek out new molecula...

Full description

Bibliographic Details
Main Authors: Gregory eHook, J. Steven Jacobsen, Kenneth eGrabstein, Mark eKindy, Vivian eHook
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-09-01
Series:Frontiers in Neurology
Subjects:
Cathepsin B
Therapeutics
Traumatic Brain Injury
Protease
drug
E64d
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00178/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00178/full

Similar Items